Stock listing

Ayurcann Holdings Corp.

Selected listing: A3ET06 · LS · EUR · DE

Ayurcann Holdings Corp. (Lang & Schwarz: A3ET06), Health Technology. Latest release Apr 13, 2026: Auxly Provides Update on Stalking Horse Bid for Ayurcann.

A3ET06:LSEURDEUpdated September 29, 2026

Ticker: Lang & Schwarz: A3ET06
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Ayurcann Holdings Corp.

Auxly Provides Update on Stalking Horse Bid for Ayurcann

April 13, 2026

Ayurcann Obtains Creditor Protection to Pursue Restructuring and Sales Process

January 30, 2026

AYURCANN REPORTS Q1 2026 SALES OF $14,638,697

November 28, 2025

AYURCANN REPORTS FISCAL YEAR 2025 RECORD SALES OF $55,446,352 IN GROSS REVENUE, FEATURING 21% YEAR-OVER-YEAR INCREASE AND PROVIDES CORPORATE UPDATE

October 28, 2025

AYURCANN REPORTS RECORD SALES GROWTH IN Q3 2025 OF $14,179,974 AND PROVIDES CORPORATE UPDATE

May 16, 2025

All Ayurcann Holdings Corp. news →

Research Ayurcann Holdings Corp.

Ayurcann Holdings Corp. company profile

View the public company page for Ayurcann Holdings Corp. on 6ix.

Ayurcann Holdings Corp. news

Read company news and market updates connected to Ayurcann Holdings Corp..

Ayurcann Holdings Corp. investor events

Find investor webinars, events, and replay context for Ayurcann Holdings Corp..